Over the past years, therapies using B cells for adoptive transfer have shown great promise for the treatment of cancers, infectious diseases, and autoimmune diseases. Many efforts have been made to engineer B cells to increase their therapeutic role.
Based on advanced technology and years of research, Creative Biolabs has developed a B cell engineering platform that creates B cells that can express therapeutic molecules. Our B cell engineering capabilities cover every stage from designing and synthesizing the requested cDNAs to editing your B cells. Our team has experience with genome editing in a large variety of cell types and also provides a one-stop solution for B cell engineering that is extremely efficient for site-specific knock-in of transgenes into a safe harbor locus in both B cell lines and primary B cells.
To achieve safe, specific, and long-term therapeutic applications, B cells present a promising platform for the delivery of therapeutic antibodies/proteins. Here, we developed a one-stop solution for engineering B cell to deliver the necessary genes for treating diseases.
Engineering B Cell Types
One-Stop Solution for B Cell Engineering
B Cell Engineering for Immunotherapy
Engineered B Cells Assessment
B Cell Differentiation Service
Creative Biolabs has developed a tailor-made B cell engineering service to support Labs, Biotechs, Medtech, and Pharma companies in their research program outsourcing. The new services combined with our expertise and values will accelerate the development of better cell and gene therapy.
Existing services are adapted according to projects. Please feel free to contact us to discuss your project.
B cell engineering has opened new possibilities in the area of cancer treatment. Creative Biolabs is pleased to offer an integrated solution to modify B cells for therapeutic delivery. Simply provide the B cells and the requested gene, then we’ll do the rest.
Fig.1 Workflow of B cell engineering.
(Creative Biolabs)